Emergence of novel avian origin H7N9 viruses after introduction of H7-Re3 and rLN79 vaccine strains to China
© 2021 Wiley-VCH GmbH..
In early 2021, roughly 6 months after the H7N9 H7-Re3 and H7N9 rLN79 vaccine strains were introduced into China, we monitored a number of H7N9 subtype avian influenza viruses, which could have escaped vaccine-induced immunity in live poultry markets (LPMs) in Yunnan, Hebei, Shanxi and Guangdong provinces, China. To investigate whether these viruses were a novel H7N9 variant of highly pathogenic avian influenza (HPAI) virus and whether they had the potential for further spread, we characterized the genetic evolution, antigenic divergence and pathogenicity of the viruses in the context of vaccine immunity. The results show further diversification in the HA gene of newly isolated HPAI H7N9 viruses compared with antigenic variants that emerged after the period of 2017-2019. There were clear antigenic differences between current vaccines and these viruses, and SPF broilers under vaccine protection could not resist virus challenges. Our study demonstrates that the current vaccine has insufficient protective capacity against the novel H7N9 variants under experimental conditions. A novel H7N9 immune escape virus has emerged. Faced with potential outbreaks, we should strengthen surveillance and update vaccine strains.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:69 |
|---|---|
| Enthalten in: |
Transboundary and emerging diseases - 69(2022), 2 vom: 24. März, Seite 213-220 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Junhong [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antigenic differences |
|---|
| Anmerkungen: |
Date Completed 31.03.2022 Date Revised 01.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/tbed.14401 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333551311 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333551311 | ||
| 003 | DE-627 | ||
| 005 | 20231225221856.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/tbed.14401 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1111.xml |
| 035 | |a (DE-627)NLM333551311 | ||
| 035 | |a (NLM)34817918 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Junhong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Emergence of novel avian origin H7N9 viruses after introduction of H7-Re3 and rLN79 vaccine strains to China |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.03.2022 | ||
| 500 | |a Date Revised 01.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 Wiley-VCH GmbH. | ||
| 520 | |a In early 2021, roughly 6 months after the H7N9 H7-Re3 and H7N9 rLN79 vaccine strains were introduced into China, we monitored a number of H7N9 subtype avian influenza viruses, which could have escaped vaccine-induced immunity in live poultry markets (LPMs) in Yunnan, Hebei, Shanxi and Guangdong provinces, China. To investigate whether these viruses were a novel H7N9 variant of highly pathogenic avian influenza (HPAI) virus and whether they had the potential for further spread, we characterized the genetic evolution, antigenic divergence and pathogenicity of the viruses in the context of vaccine immunity. The results show further diversification in the HA gene of newly isolated HPAI H7N9 viruses compared with antigenic variants that emerged after the period of 2017-2019. There were clear antigenic differences between current vaccines and these viruses, and SPF broilers under vaccine protection could not resist virus challenges. Our study demonstrates that the current vaccine has insufficient protective capacity against the novel H7N9 variants under experimental conditions. A novel H7N9 immune escape virus has emerged. Faced with potential outbreaks, we should strengthen surveillance and update vaccine strains | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a antigenic differences | |
| 650 | 4 | |a evolution | |
| 650 | 4 | |a immune escape | |
| 650 | 4 | |a influenza virus | |
| 650 | 4 | |a novel H7N9 viruses | |
| 650 | 7 | |a Hemagglutinin Glycoproteins, Influenza Virus |2 NLM | |
| 650 | 7 | |a Influenza Vaccines |2 NLM | |
| 650 | 7 | |a Vaccines |2 NLM | |
| 700 | 1 | |a Liu, Zhaojie |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Ke |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Xiao |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Lingyu |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Mengmeng |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Yifan |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Tengfei |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Xinkai |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Shumin |e verfasserin |4 aut | |
| 700 | 1 | |a Xin, Aiguo |e verfasserin |4 aut | |
| 700 | 1 | |a Liao, Ming |e verfasserin |4 aut | |
| 700 | 1 | |a Jia, Weixin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Transboundary and emerging diseases |d 2008 |g 69(2022), 2 vom: 24. März, Seite 213-220 |w (DE-627)NLM178784648 |x 1865-1682 |7 nnns |
| 773 | 1 | 8 | |g volume:69 |g year:2022 |g number:2 |g day:24 |g month:03 |g pages:213-220 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/tbed.14401 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 69 |j 2022 |e 2 |b 24 |c 03 |h 213-220 | ||